CD44 and breast carcinoma: However, CD44 overexpression only slightly mitigated the levels of proapoptotic proteins BID and BAX, which were increased in MARCH8-GFP-overexpressing cells (Figure 5F), suggesting that additional targets of MARCH8 are responsible for the alteration of proapoptotic signals in breast cancer cells.